In the News:
Steps for Medicare Reform?
The political pressures
of the coming election cycle have made it virtually
impossible for Congress to reach agreement on any
major Medicare-related legislation.
What's New in
- Long-Term Care After Hematopoietic-Cell
Transplantation in Adults
After successful transplantation, patients
remain at risk for diseases common in the general
population, as well as for health problems directly
related to transplantation.
This article can be found
in the New England Journal of Medicine 2002; 347:36-42,
Jul 4, 2002.
- No pain, no gain? If you've broken
a bone, choose your painkiller with care.
Some of the new non-steroidal anti-inflammatory
drugs (NSAIDs) may delay or even prevent the healing
This article by Danny Penman
can be found in the Journal of Bone and Mineral
Research (vol. 17, p 903) or in New
Scientist June 2002, page 6.
stem cell transplantation for primary systemic amyloidosis
High-dose melphalan with autologous blood
stem cell transplantation (SCT) can reverse the disease
process in selected patients with primary systemic
amyloidosis (AL); however, SCT for AL remains controversial
because of the treatment-related mortality in patients
with cardiac and multi-system organ involvement.
Items of Interest:
- "Return of Thalidomide"
Thalidomide, the notorious drug which caused horrendous
birth defects in the 1950s and 1960s, is close to
making a comeback as an anticancer drug. Drug firm
Celgene of Warren, New Jersey, has applied to European
drug authorities for permission to sell thalidomide
to treat multiple myeloma, a fatal cancer of the bone
marrow. In clinical trials the drug performed well
against the disease. It will take Europe seven months
or more to reach a verdict on the drug, which will
not be prescribed to pregnant women or those considering
This article is from New
Scientist June 2002, page 5.
As featured in this month's issue
of CURE Magazine:
Important Dates to
Peripheral Neuropathy Teleconference
Tuesday, July 30, 2002
1:00 p.m. - 2:00 p.m. ET
This teleconference is free, but participants must register
online or by calling (800) 813-HOPE.
Patient & Family Seminar: Chicago, IL
August 16th and 17th
Myeloma Foundation Multiple Myeloma Awareness Week
August 26th - September 1st
of Hope: Making A World of Difference 12th Anniversary
Patient & Family Seminar: Seattle, WA
November 8th and 9th
Patient & Family Seminar: Los Angeles, CA
January 24-25, 2003
Total-Body Irradiation, and Peripheral Stem Cell Transplantation
Compared With Combination Chemotherapy in Treating Patients
With Previously Untreated Multiple Myeloma.
Chemotherapy With or Without Interferon alfa in Treating
Patients With Previously Untreated Multiple Myeloma.
Chemotherapy in Treating Patients With Multiple Myeloma.
Therapy and Blood or Marrow Transplantation in Patients
With Severe Hematologic Malignancy.
Alfa in Patients With Multiple Myeloma and Chemotherapy
Regimens For the Prevention of Delayed Nausea After
Chemotherapy in Patients With Chemotherapy-Naive Cancer.
Myeloma Quilt of Courage
All the squares for the first quilt have been sold!
We are now taking orders for the second quilt. Deadline
will be September 27th.
Help Us Help Others...
As a non-profit organization, the IMF is
completely dependent on the support of our members. Please
consider showing your support by making a tax-deductible
donation today. Donations in honor of a friend or family
member make great gifts and are a wonderful way to celebrate
a special occasion. You
can donate online or by calling the IMF at (800) 452-CURE.
We sincerely thank you for your support.
New to the IMF Myeloma
what you've been missing by viewing previous issues online!
Tell A Friend...
The Myeloma Minute is
a great way to stay abreast of the latest developments
within the myeloma community. We hope you'll share this
information with friends, family members and physicians
and encourage them to sign up for their own copy by
forwarding this message. New
users can register by clicking here.